Vaxcyte OverviewVaxcyte Other Income Expense Net
Other Income/Expense Net for PCVX.
Quarterly Other Income/Expense
$25.23M
↓ 37.05% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$142.20M
↑ 12.64% YoY
Trailing 12 months ending Mar 31, 2026